您的位置: 首页 > 农业专利 > 详情页

FORMES POSOLOGIQUES ORALES PHARMACEUTIQUES POUR LE TRAITEMENT DES TROUBLES MÉTABOLIQUES ET DES MALADIES CONNEXES PAR LA LIBÉRATION ORCHESTRÉE D'ENTÉROKINASES
专利权人:
Aphaia Pharma AG
发明人:
申请号:
EP18211446.2
公开号:
EP3666262A1
申请日:
2018.12.10
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
The present invention relates to pharmaceutical oral dosage forms releasing compounds in specific parts of the small intestine of a subject, wherein said compounds stimulate enteroendocrine cells in the subject's jejunum and lower small intestine to release one or more enterokines. The present invention also relates to a method of producing such pharmaceutical oral dosage forms. The pharmaceutical oral dosage forms of the invention are particularly for use in the treatment and prevention of metabolic conditions or diseases, osteoporosis, malabsorption conditions, neurodegenerative diseases, conditions of impaired gastro-intestinal function and cardiovascular diseases.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充